コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 votal advancements in tissue engineering and regenerative medicine.
2 ramming, which has important implications in regenerative medicine.
3 tuned spatiotemporal manner for personalized regenerative medicine.
4 a bank of these stem cells for personalized regenerative medicine.
5 e increasingly opening up new avenues within regenerative medicine.
6 organism, making them an invaluable tool in regenerative medicine.
7 es for fields such as tissue engineering and regenerative medicine.
8 NT-like protrusions as a delivery system for regenerative medicine.
9 ease modeling, toxicology, cell therapy, and regenerative medicine.
10 ion in disease modeling, drug screening, and regenerative medicine.
11 tions across cell biology, biomaterials, and regenerative medicine.
12 lications in diagnostics, drug delivery, and regenerative medicine.
13 nstrated considerable therapeutic benefit in regenerative medicine.
14 on of in vitro differentiation protocols for regenerative medicine.
15 h applications across tissue engineering and regenerative medicine.
16 in synthetic biology, disease modeling, and regenerative medicine.
17 the knowledge from developmental studies for regenerative medicine.
18 of these processes to stem cell biology and regenerative medicine.
19 PSC-derived lineages in disease modeling and regenerative medicine.
20 l applications for both disease modeling and regenerative medicine.
21 cessary prior to use in drug development and regenerative medicine.
22 ore find application in cancer treatment and regenerative medicine.
23 plinary studies, including organogenesis and regenerative medicine.
24 ardiac reprogramming holds great promise for regenerative medicine.
25 ed is also of great interest in the field of regenerative medicine.
26 nsplantation, graft versus host disease, and regenerative medicine.
27 e body makes them invaluable in the field of regenerative medicine.
28 o features are therefore highly desirable in regenerative medicine.
29 yocardium with new tissue is a major goal of regenerative medicine.
30 studying cardiac biology, drug discovery and regenerative medicine.
31 Thus, our study advances the goals of liver regenerative medicine.
32 ationale of using appropriate stem cells for regenerative medicine.
33 t agonists for translational applications in regenerative medicine.
34 esident progenitors with great potential for regenerative medicine.
35 used biomaterials for tissue engineering and regenerative medicine.
36 serves to advance developmental research and regenerative medicine.
37 ructs in the field of tissue engineering and regenerative medicine.
38 ility in the areas of tissue engineering and regenerative medicine.
39 cipline to facilitate stem cell research and regenerative medicine.
40 y, immunology, and embryonic stem cell-based regenerative medicine.
41 o differentiation and future applications in regenerative medicine.
42 ventricular noncompaction cardiomyopathy and regenerative medicine.
43 could open new opportunities in the field of regenerative medicine.
44 region-restricted adult tissue stem cells in regenerative medicine.
45 tems have impeded their use in translational regenerative medicine.
46 for their widespread distribution and use in regenerative medicine.
47 or tissue engineering, disease modeling, and regenerative medicine.
48 in many areas, such as biomedical devices or regenerative medicine.
49 xt generation of researchers in the field of regenerative medicine.
50 the potential therapeutic role of hypoxia in regenerative medicine.
51 otent stem cells (hPSCs) is a major goal for regenerative medicine.
52 l therapy represents a promising strategy in regenerative medicine.
53 egenerate should provide important clues for regenerative medicine.
54 ls for drug screening, disease modeling, and regenerative medicine.
55 proteins in the context of drug delivery and regenerative medicine.
56 ar biomaterials are promising candidates for regenerative medicine.
57 s remains a concern for disease modeling and regenerative medicine.
58 ages for autologous, cell-based therapies in regenerative medicine.
59 portunities for studying development and for regenerative medicine.
60 mplex tissues has the potential to transform regenerative medicine.
61 niche, which may have major applications in regenerative medicine.
62 edical application such as drug delivery and regenerative medicine.
63 ls (PSC) have the potential to revolutionize regenerative medicine.
64 ate macrophage phenotype as a useful tool in regenerative medicine.
65 ity in the efficient production of cells for regenerative medicine.
66 lize human pluripotent stem cells (hPSCs) in regenerative medicine.
67 cell niches are modulated provides clues for regenerative medicine.
68 cytes for use in cardiovascular research and regenerative medicine.
69 therapy and biomaterials for applications in regenerative medicine.
70 e major stem cells used for cell therapy and regenerative medicine.
71 for basic developmental biology research and regenerative medicine.
72 e implications for harnessing Wnt agonism in regenerative medicine.
73 rstanding human disease, drug discovery, and regenerative medicine.
74 tion of other tissue-specific stem cells for regenerative medicine.
75 amental aspects of developmental biology and regenerative medicine.
76 ogels may find broad utility in the field of regenerative medicine.
77 ding tissue SCs has led to major advances in regenerative medicine.
78 c cells into neurons holds great promise for regenerative medicine.
79 ns for translational applications, including regenerative medicine.
80 (hiPSCs) have potential for personalized and regenerative medicine.
81 h a pluripotent state, has great promise for regenerative medicine.
82 to a cascade of technological innovations in regenerative medicine.
83 us stem cells represents an ultimate goal in regenerative medicine.
84 st valuable sources of somatic stem cells in regenerative medicine.
85 fields, from evo-devo to cancer research and regenerative medicine.
86 essment, may improve clinical application in regenerative medicine.
87 ensure hiPSC quality for drug discovery and regenerative medicine.
88 f great interest for biomedical research and regenerative medicine.
89 es to improve cell and tissue production for regenerative medicine.
90 and appendage regeneration is a key goal of regenerative medicine.
91 the complex nature of congenital disease and regenerative medicine.
92 ntial impact of nanotechnology in MSC-driven regenerative medicine.
93 gh-throughput drug screening devices, and in regenerative medicine.
94 ell heterogeneity, complicating their use in regenerative medicine.
95 l solution to overcome this key challenge in regenerative medicine.
96 e and suggest new therapeutic approaches for regenerative medicine.
97 tent stem (iPS) cells holds great promise in regenerative medicine.
98 cell types and thus have great potential for regenerative medicine.
99 been a long sought-after but elusive goal in regenerative medicine.
100 tages for their use in disease modelling and regenerative medicine.
101 become a promising tool for cell therapy in regenerative medicine.
102 ) would have broad reaching implications for regenerative medicine.
103 safety of PSC-derived cellular therapies for regenerative medicine.
104 r in vitro tissue models and applications in regenerative medicine.
105 otential use of viscoelastic biomaterials in regenerative medicine.
106 esis in the context of blood pathologies and regenerative medicine.
107 tic framework to evaluate future research on regenerative medicine.
108 ditions is emerging as a promising option in regenerative medicine.
109 2 as a therapeutic target in stem cell-based regenerative medicine.
110 ns for the generation of bona fide hPSCs for regenerative medicine.
111 delivers a powerful technique to facilitate regenerative medicine.
112 in PSCs, and improve their effectiveness in regenerative medicine.
113 ations, especially in tissue engineering and regenerative medicine.
114 as the foundation of tissue engineering and regenerative medicine.
115 tional applications in skeletal muscle-based regenerative medicine.
116 EVs and their cargo as therapeutic agents in regenerative medicine.
117 regeneration with potential implications in regenerative medicine.
118 ards informing the design of therapeutics in regenerative medicine.
119 nctionality, and potentially high impact for regenerative medicine.
120 ay be benefited from cell therapies based on regenerative medicine.
121 modulating the YAP oncoprotein in cancer and regenerative medicine.
122 of human astrocytes for disease modeling and regenerative medicine.
123 ue engineering processes for applications in regenerative medicine.
124 ansion, which will have a positive impact in regenerative medicine.
125 ass of therapeutics to unlock the promise of regenerative medicine.
126 more mature cardiomyocytes for research and regenerative medicine.
127 translational research in biotechnology and regenerative medicine.
128 y explored in studies of pathophysiology and regenerative medicine.
129 how findings from these studies will advance regenerative medicine.
130 mally invasive therapeutics a viable tool in regenerative medicine.
131 eatic islet cells, and their applications in regenerative medicine.
132 n the field of neurodegenerative disease and regenerative medicine.
133 ucial for specific therapeutic targeting and regenerative medicine.
134 elds of drug delivery, tissue engineering or regenerative medicine.
135 s, suggesting an applicability in myocardial regenerative medicine.
138 netic resonance imaging (MRI) is crucial for regenerative medicine, allowing verification that the tr
139 materials, in particular tissue engineering, regenerative medicine and also in the design of more rel
142 luding cell therapy, tissue engineering, and regenerative medicine and are frequently used in preclin
147 ransplantation has shown emerging promise in regenerative medicine and dental translational practice.
148 have become a standard platform not only for regenerative medicine and developmental biology but also
153 ently produce cardiovascular progenitors for regenerative medicine and drug discovery applications.
155 these cells are considered to be useful for regenerative medicine and drug screening for liver disea
160 investigation of the roles of stem cells in regenerative medicine and pathogenesis of various diseas
162 ting, mRNA vaccination, and other mRNA-based regenerative medicine and protein replacement therapies.
163 VML-injured patients and clinicians approach regenerative medicine and rehabilitation following injur
164 ) cells, a process that has implications for regenerative medicine and rejuvenation strategies(4).
165 particular emphasis on diseases amenable to regenerative medicine and strategies to deal with barrie
166 proaches to construct functional tissues for regenerative medicine and synthetic biology as well as n
169 l applications including tissue engineering, regenerative medicine, and cell and therapeutic delivery
171 elial cell-seeding densities are required in regenerative medicine, and existing techniques are inade
172 s such as drug delivery, tissue engineering, regenerative medicine, and soft robotics, in which struc
175 e potential to accelerate the development of regenerative medicine applications based on implantation
176 muCPP) to create a complex CNS structure for regenerative medicine applications in the spinal cord.
177 ted unprecedented potential for a variety of regenerative medicine applications including novel drug
178 oaches to direct cellular behaviour for many regenerative medicine applications including those for p
179 ve production of patient-specific niPSCs for regenerative medicine applications, including disease mo
190 d as a novel tool for cellular and acellular regenerative medicine approaches for osteoarthritis (OA)
191 nant of RPE phenotype, with implications for regenerative medicine approaches that utilise stem cell-
196 ent efforts in cellular disease modeling and regenerative medicine are limited by the paucity of cell
197 vitro tissue models, tissue engineering, and regenerative medicine are provided to further motivate f
199 port the view that hAEC are instrumental for regenerative medicine as well as in therapeutic applicat
200 nerate various types of organ constructs for regenerative medicine as well as to address pressing bio
203 terial microarrays hold enormous promise for regenerative medicine because of their ability to accele
204 s that have recently emerged as key tools in regenerative medicine because some of them can function
205 tural retinoids, evaluated in the context of regenerative medicine, brain, cancer, skin, and immune d
206 caffolds unveils great potential not only in regenerative medicine but also in drug testing and disea
207 ibroblasts holds potential as a strategy for regenerative medicine but until now has only been shown
208 ent stem (iPS) cells have great potential in regenerative medicine, but this depends on the integrity
209 lay a pivotal role in tissue engineering and regenerative medicine by functioning as biomimetic subst
210 folds have shown promise for applications in regenerative medicine by providing a natural extracellul
211 that in vivo reprogramming may revolutionize regenerative medicine by using a patient's own internal
212 n induced pluripotent stem cell (iPSC)-based regenerative medicine can be applied; however, mass prod
214 ions in the fields of assisted reproduction, regenerative medicine, cancer, metabolic disorders and a
217 yocytes (hiPSC-CMs) as tissue transplants in regenerative medicine depends on cell-surface marker-bas
218 and an emerging model organism in genomics, regenerative medicine, developmental biology and ecotoxi
219 e great potential as a human model system in regenerative medicine, disease modeling, and drug screen
220 of internal order and have important uses in regenerative medicine, drug delivery, and soft matter el
221 s logistical limitations on transplantation, regenerative medicine, drug discovery, and a variety of
222 be used for various applications, including regenerative medicine, drug sensitivity testing, gene ex
223 ESCs) is critical for further application in regenerative medicine, drug testing and studies of funda
224 n of Wnt signaling has untapped potential in regenerative medicine due to its essential functions in
225 broad applications in tissue engineering and regenerative medicine, followed by a summary and perspec
226 of importance to the development of improved regenerative medicine for patients with white matter dis
227 ntinues to be made in the field of stem cell regenerative medicine for the treatment of cardiovascula
228 new opportunities for tissue engineering and regenerative medicine, generating knowledge and tools fo
229 m adult tissues offer tangible potential for regenerative medicine, given their feasibility for autol
231 studies of human infectious disease, cancer, regenerative medicine, graft-versus-host disease, allerg
232 efficacy of mesenchymal stem cells (MSCs) in regenerative medicine has been documented in many clinic
236 s has important potential in biomedicine and regenerative medicine; however, it often requires comple
240 nctional food products, and in Cosmetics and Regenerative Medicine in the development of formulations
242 mize the protocol for future applications in regenerative medicine, in which components of undefined
244 ential applications in stem cell biology and regenerative medicine, including precision medicine.
245 estigations aiming at the manufacturing of a regenerative medicine-inspired bioartificial endocrine p
246 Stem cell tracking in cellular therapy and regenerative medicine is an urgent need, superparamagnet
251 A goal for periodontal tissue engineering/regenerative medicine is to restore oral soft and hard t
253 cells (MSCs) are a promising cell source for regenerative medicine, ischemia-induced endoplasmic reti
254 t) unknown challenges, pursuit of myocardial regenerative medicine mediated by adult stem cell therap
255 f applications including neural engineering, regenerative medicine, multi-functional sensors and actu
257 lls, thus addressing a critical challenge in regenerative medicine of achieving cell-free scaffold-ba
258 otent stem cells (embryonic and induced) for regenerative medicine of incurable diseases, immunothera
259 tors the location of SPIO-labelled cells for regenerative medicine of the knee with MRI, histology, a
260 tunities in emerging scientific areas (e.g., regenerative medicine, omics technology, data science, p
261 d their potential therapeutic application in regenerative medicine or angiogenesis-related diseases i
262 pluripotent stem cells are a cornerstone of regenerative medicine owing to their ability to give ris
263 rol, and demonstrate the potential to impact regenerative medicine, pharmacology and electronic thera
264 for Regenerative Medicine (CIRM) and the UK Regenerative Medicine Platform (UKRMP) have similar obje
265 atures have established NDs as an invaluable regenerative medicine platform, with a broad range of cl
266 m cells as a prerequisite for harnessing the regenerative-medicine potential of these cells in the cl
268 is critical when validating biomaterials for regenerative medicine purposes and requires high-tech an
271 vances in both evolutionary cell biology and regenerative medicine require an understanding of how no
272 PSC)-derived neurons in disease modeling and regenerative medicine requires analysis in complex funct
274 gan transplantation in fostering progress in regenerative medicine (RM) because the future of no othe
276 verse potential applications in research and regenerative medicine, so a readily available source cou
277 her development, this approach may provide a regenerative medicine solution to uterine factor inferti
279 f non-collagenous matrix and suggesting that regenerative medicine strategies should change focus fro
282 more mature field of tissue engineering and regenerative medicine (TERM), established on the belief
283 This paper presents the development of a new regenerative medicine that combines 3D bio-printing and
284 ath forward to application of these cells in regenerative medicine that perhaps may solve several pro
286 rt biomedical applications of 2D nanoclay in regenerative medicine, therapeutic delivery, and additiv
287 , gene therapy, drug screening, and emerging regenerative medicine therapies are fundamentally relian
288 y applications, including the development of regenerative medicine therapies to manage diseases affec
290 mmes has been proposed as a new paradigm for regenerative medicine, therefore, a complete understandi
291 p progenitor organoids may be implemented in regenerative medicine, tissue engineering, and pharmaceu
293 tors differentiate into MSNs is critical for regenerative medicine to develop specific differentiatio
294 c stem/progenitor cells (hCPCs) may serve in regenerative medicine to repair the infarcted heart.
295 genome editing easier, and may be useful in regenerative medicine, unravelling heterogeneity in dise
297 on the paradigm of in vivo reprogramming for regenerative medicine, while pointing to hurdles that mu
299 MG53 as an attractive biological reagent for regenerative medicine without interference with glucose
300 s an important target in cancer research and regenerative medicine; yet, on the cellular level, many